Physician profile
Ernest O Sutton
NPI 1801868146
$1,205.67
in general payments reported to CMS, 2019-2025
17 companies · $153 in 2025
The $153 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $26.74 · 2021: $160 · 2022: $228 · 2023: $237 · 2024: $207 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $216.26 | 2019-2025 | Dyanavel Xr |
| Corium, LLC | $198.34 | 2021-2024 | Azstarys, Azstarys |
| Ironshore Pharmaceuticals INC. | $141.43 | 2022-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $139.14 | 2022 | |
| Pfizer INC. | $106.41 | 2020-2023 | |
| Merck Sharp & Dohme LLC | $83.91 | 2024-2025 | Proquad, M-M-R II, Vaxneuvance |
| Collegium Pharmaceutical, INC. | $64.45 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $53.75 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $49.38 | 2020-2023 | Flumist Quadrivalent |
| Avion Pharmaceuticals | $29.23 | 2023 | Methylphenidate Hydrochloride |
| Adlon Therapeutics L.P. | $23.76 | 2019 | |
| Neos Therapeutics, Lp | $20.40 | 2019 | |
| Supernus Pharmaceuticals, INC. | $17.83 | 2023 | Qelbree |
| Genentech USA, INC. | $17.35 | 2019 | |
| Cranial Technologies, INC | $15.95 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $14.80 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ernest Sutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.